Replies to post #60202 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

JB, I wasn’t referring to you. You state your view in a reasonable manner. We’ll see if Lombardo can get deals. That is all I really want from him. Aside from the capitalization issue is the company really in bad shape? NEO active, great data to be released soon, EMA clock ticking, etc. we simply need at least one good partnership. If he cannot get that done soon then I will suspect something is not right. If he does, then we are in good shape going forward.

[Simple Steve]

JB, ignore him. He always assigns some sort of emotional reason to people who differ with his opinion. He said I was emotionally unstable too. lol. But you're 100% right JB. Of course dilution at $2 is bad news. And of course the longer ADXS takes to get its drugs to market, if ever, the greater the odds that some other company develops a better drug that makes ours obsolete. Eventually it will happen. Science marches on with or without ADXS. That's why all these delays and holds are disappointing and that's why the SP has tanked. Investors aren't always the most patient bunch and will move on to better investment opportunities.